Crossmark

Ponatinib both as an effective bridge to allogeneic hematopoietic stem cell transplantation and as posttransplant maintenance therapy in a chronic myeloid leukemia patient with myeloid blast crisis

Crossref DOI link: https://doi.org/10.1016/j.htct.2021.04.007

Published Print: 2023-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Küçükyurt, Selin https://orcid.org/0000-0001-8742-3388
Kelezoğlu, Alihan https://orcid.org/0000-0002-6347-0638
Elverdi, Tuğrul https://orcid.org/0000-0001-9496-5353
Özmen, Deniz

Ar, Muhlis Cem

Eşkazan, Ahmet Emre https://orcid.org/0000-0001-9568-0894
License Information

Text and Data Mining valid from 2023-04-01

Version of Record valid from 2021-05-28
More Information

This article is maintained by: Elsevier

Article Title: Ponatinib both as an effective bridge to allogeneic hematopoietic stem cell transplantation and as posttransplant maintenance therapy in a chronic myeloid leukemia patient with myeloid blast crisis

Journal Title: Hematology, Transfusion and Cell Therapy

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.htct.2021.04.007

Content Type: article

Copyright: © 2021 Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below